ducovest

VBR:ARCA-Vanguard Small-Cap Value ETF - DNQ (USD)

ETF | Small Value | NYSE Arca

Last Closing

USD 198.45

Change

0.00 (0.00)%

Market Cap

USD 9.17B

Volume

0.21M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization value stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Small Cap Value Index, a broadly diversified index of value stocks of small U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Company Website : www.vanguard.com

Currency: USD

Country : USA

Inception Date: 26/01/2004

Primary Benchmark: CRSP US Small Cap Value TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.08%

Management Expense Ratio: 0.07 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TARS Tarsus Pharmaceuticals Inc 0.51 %
DOCU DocuSign Inc 0.47 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-01 )

Largest Industry Peers for Small Value

Symbol Name Mer Price(Change) Market Cap
IJS iShares S&P Small-Cap 600 Valu.. 0.25 %

N/A

 USD 6.87B
DES WisdomTree U.S. SmallCap Divid.. 0.38 %

N/A

 USD 1.94B
XSVM Invesco S&P SmallCap Value wit.. 0.39 %

N/A

 USD 0.79B
XSLV Invesco S&P SmallCap Low Volat.. 0.25 %

N/A

 USD 0.32B
PXSV Invesco S&P SmallCap Value wit.. 0.39 %

N/A

 N/A
SLYV SPDR® S&P 600 Small Cap Value.. 0.15 %

N/A

 N/A
VIOV Vanguard S&P Small-Cap 600 Val.. 0.20 %

N/A

 N/A
FDM First Trust Dow Jones Select M.. 0.60 %

N/A

 N/A
RFV Invesco S&P MidCap 400® Pure .. 0.35 %

N/A

 N/A
RWJ Invesco S&P SmallCap 600 Reven.. 0.39 %

N/A

 N/A

ETFs Containing VBR

ABCS Alpha Blue Capital US Sma.. 9.83 % 0.00 %

N/A

 USD 9.55M
FDVL 8.53 % 0.00 %

N/A

 N/A
GMOM 0.00 % 0.59 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.27% 100% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.27% 100% F 63% D
Trailing 12 Months  
Capital Gain 16.50% 92% A 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.50% 92% A 67% D+
Trailing 5 Years  
Capital Gain 61.46% 67% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.46% 67% D+ 75% C
Average Annual (5 Year Horizon)  
Capital Gain 13.44% N/A N/A 76% C+
Dividend Return 15.52% N/A N/A 76% C+
Total Return 2.08% N/A N/A 46% F
Risk Return Profile  
Volatility (Standard Deviation) 26.29% N/A N/A 39% F
Risk Adjusted Return 59.04% N/A N/A 77% C+
Market Capitalization 9.17B 100% F 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike